We are live on ! Find out more
ECTE

ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE

Delisted

ECTE was delisted on the 11th of July, 2016.

1 hedge funds and large institutions have $1K invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $1K → $1K ($0)

50% less funds holding

Funds holding: 21 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Edge Wealth Management
New York
$1K

ECTE Hedge Fund Activity: Q2 2017 in Review

1 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q2 2017, worth a combined $1K — unchanged from a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ECTE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

  • 1 institutional investor held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q2 2017, down from 2 in Q1 2017.
  • Funds reported $1K of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q2 2017, unchanged quarter-over-quarter.
  • 0 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q2 2017 and 1 closed out, a net change of -1 holder.

Based on aggregated 13F filings for Q2 2017.